Specialized, hands-on support for your aesthetics and cosmetics studies. Weâre all in.
For over two decades, Innovaderm has been the leading dermatology CRO and one of the largest dermatology Clinical Research Units (CRU) in North America. As we continue to grow and support immune-mediated diseasesâincluding those in rheumatology, a therapeutic area inextricably linked to dermatologyâwe have rebranded the CRO side of our business to Indero. Our CRU will retain the name Innovaderm and will continue to conduct dermatology studies.
Aesthetic medicine is a rapidly evolving field that significantly enhances patients’ quality of life through innovative treatments and procedures. With over 25 years of dedicated experience in both aesthetic and medical aesthetics, Indero has been at the forefront of this transformation. With deep medical expertise and extensive operational experience, we can help you design a study that meets scientific objectives with the well-being of subjects in mind. Whether it’s developing new dermal fillers, neurotoxins, or other aesthetic treatments, we are committed to advancing the field with precision and care.
At Indero, we understand the nuances related to patient and healthy volunteer recruitment, optimizing data integrity through informed selection of assessment tools and sites, and streamlined strategies to manage cost-effective studies leveraging our aesthetic dermatology know-how.
Indero offers a full-service in-house model for aesthetics clinical trials. From design to execution, we provide customized solutions to meet your studyâs unique needs.
Indero is a global clinical leader in aesthetics and medical dermatology with over a quarter centuryâs experience serving a broad range of indications, patient populations, administration routes, and drug classes. From protocol design to data delivery, we offer a full-service approach that equips biotech and pharmaceutical sponsors with the scientific rigor and targeted expertise to help bring novel therapies to people with skin diseases. Our operations span across the world, with capabilities in North America, Europe, Latin America, and Asia Pacific. Our dermatology connections include over 3,100+ investigators, making us a trusted partner for efficient, effective aesthetics trials at a global scale.
Innovaderm is a dermatology-focused Clinical Research Unit (CRU) well suited for single or multicenter dermatology studies. With a database of +90,000 patients, Innovaderm CRU has a dedicated team of study coordinators, lab technicians, research nurses, data entry specialists, regulatory specialists, and recruitment professionals.
Indero has cultivated relationships with 3,100+ dermatology investigators around the world, actively contributing to the advancement of novel therapies for people with skin conditions. Developed over years of working together, we have strong relationships with these sites, allowing us to select the right sites for your trial. Our sites are ready to meet your enrollment requirements, ensuring your timelines and quality metrics are met.
An aesthetic study involving an injectable implant with more than 200 subjects enrolled.
Meet our esteemed dermatologists, each bringing decades of invaluable experience to your trials. Their expertise is complemented by our dedicated operational CRO team, ready to support you at every stage.
Executive Chairman and Founder
Chief Medical and Scientific Officer
Dermatologist, Medical Monitor
Dermatologist, Medical Monitor Associate
An Aesthetics Dermatology CRO manages and supports clinical trials for cosmetic and aesthetic dermatology products. They provide expertise in patient recruitment, regulatory compliance, and data management to ensure the success of your aesthetics dermatology study.
When selecting an aesthetics dermatology CRO, consider these key factors:
A specialized CRO enhances your trial by providing medical, scientific, and clinical dermatology expertise in addition to tailored patient engagement strategies and streamlined operations. Their deep understanding of regulatory requirements and established dermatology-specific networks can lead to more efficient trial execution and improved patient outcomes, ultimately advancing treatment options in this critical field.
Wherever
Youâre Going,
Weâre all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
Contact form on home page
We orchestrate all study activities and deliverables, including the site selection process, budget and contract negotiations, patient engagement, and recruitment enrollment projections, all while respecting your study timelines.
We provide clinical oversight to protect subject safety and maintain data integrity. Our responsive medical monitors work directly with sites to address issues quickly, ensuring adherence and reliable data that keep your rheumatology trials on track.
Our pharmacovigilance services span various therapeutic areas and track, assess, and report safety data to manage your trial risks effectively. Through continuous monitoring and regulatory reporting, we ensure subject safety, providing you with the confidence and clarity you need.
Our extensive biometric services cater to all your biostatistics and data management requirements, meticulously aligned with your rheumatology study goals and other medical fields. We offer a range of services, including adaptive design, strategic statistical consulting, sample size and power calculations, database design, medical coding, and thorough data validation, review, and cleaning.
With deep expertise and vast operational experience, we can help you design an innovative and efficient patient-centric rheumatology study that meets your scientific objectives while optimizing your financial investment. We engage with key opinion leaders to shape trial designs leading to improved study site engagement.
We can help you navigate the global regulatory landscape and provide clinical development consulting, covering end-to-end needs, including drug and device submissions, medical and scientific writing, clinical pre-feasibility, scientific support, and even meeting with regulatory agencies.
Our long-standing relationships with key opinion leaders and highly performing sites result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on the competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
We provide expert regulatory writing services, with clinical study protocols designed and drafted by our team of clinical scientists, dermatologists, and rheumatologists, all according to your requirements and specifications.
Our quality assurance service ensures the highest standards of compliance and data integrity. We implement rigorous quality control processes to identify and mitigate risks early.Â
Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et dâopĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue dâĂ©tendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.